Delivery Order SPE2DB20D1100-SPE2DB24FC5Y0
Award Date
7/5/24
Potential Completion Date
7/26/24
Potential Value
$51K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $46,814.35 and is for the delivery of Ultomiris 300 mg/3 ml vials. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through March 26, 2024. AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly...
This federal contract award, valued at $96,889.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ultomiris, a 1,100 mg/11 ml specialty drug vial, with a performance period through January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $26,285.85 and provides for the delivery of Ultomiris, a 1,100 mg/11 mL vial medication, with a performance period through April 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ultomiris 1,100 mg/11 ml vials. The award has a ceiling value of $26,285.85 and a period of performance through April 28, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Ultomiris, a prescription medication, with a ceiling value of $62,434.92 and a completion date of May 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger...
This federal contract award is for the delivery of Ultomiris, a 1,100 mg/11 ml vial medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $94,507.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 9, 2021 with a completion date of September 30, 2021. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $46,826.19, is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication, with a completion date of September 10, 2024. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,779.26, is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a for-profit organization...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Ultomiris (ravulizumab-cwvz), a rare disease treatment medication. The contract is a Delivery Order with a Firm Fixed Price valued at $93,652.38. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $106,187.70 firm fixed-price contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...